Chemicals giant EI DuPont de Nemours & Co.(DD), commonly called DuPont, announced that Lamberto Andreotti, Chief Executive Officer of Bristol-Myers Squibb Co (BMY), will be a nominee for election to its board of directors during the company's annual stockholders meeting on April 25.
Andreotti, 61, has been CEO of Bristol-Myers Squibb since 2010. Previously,he served as its president and chief operating officer responsible for all of Bristol-Myers Squibb's pharmaceutical operations worldwide. Andreotti, a member of Bristol-Myers Squibb's board of directors since 2009, has led a broad range of businesses and regions since joining the company in 1998.
For comments and feedback: editorial@rttnews.com